Bo Bai

Dr Bo Bai worked as a clinical pharmacist at a hospital in Beijing, China between 2005 and 2009. He completed his PhD training in molecular pharmacology and vascular ageing at the University of Hong Kong in 2014. He currently holds the post of Research Fellow in Agency for Science, Technology and Research (A STAR), Singapore and investigates molecular pathogenesis of heart failure. He has co-authored about 30 publications regarding cardiovascular diseases and pharmaceutical care for patients. He and colleagues revealed the roles of SIRT1 in endothelial senescence and atherosclerosis. This work was published in Circulation (2012) and highlighted by ‘Circulation Editor’, ‘The Asia-Pacific International Molecular Biology Network’ and the ‘International Atherosclerosis Society’.

Education

• Doctor of Philosophy (PhD) 香港大學 (2009 — 2013)

Companies

• Clinical Research Fellow The Shenzhen Second People's Hospital (2019)
• Honorary Assistant Professor 香港大學 (2016)
• Postdoctoral Research Fellow A*STAR - Agency for Science, Technology and Research (2014 — 2019)
• Honorary Research Associate 香港大學 (2014 — 2016)
• Research Associate The University of Hong Kong (2013 — 2014)
• Senior Clinical Pharmacist China-Japan friendship hospital (2005 — 2009)